ECS PROGASTRIN SA has a total of 26 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are SINGH BIOTECHNOLOGY LLC, PROGASTRINE ET CANCERS S A R L and SINGH MOLECULAR MEDICINE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Singapore | 3 | |
#6 | United States | 3 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | Taiwan | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Prieur Alexandre | 16 |
#2 | Joubert Dominique | 8 |
#3 | Alexandre Prieur | 2 |
Publication | Filing date | Title |
---|---|---|
AU2019228339A1 | Progastrin as a biomarker for immunotherapy | |
TW201940881A | Combining progastrin detection with other cancer biomarkers in cancer diagnosis |